Main Menu (Mobile)- Block

Main Menu - Block

Host ZCCHC3 blocks HIV-1 infection and production by a dual mechanism

Our Research / Publications
janelia7_blocks-janelia7_biblio_header | block
iScience. 2024 Jul;. doi: 10.1101/2023.06.14.544911
View Article on
Host ZCCHC3 blocks HIV-1 infection and production by a dual mechanism Lippincott-Schwartz Lab
Yi Binbin, Tanaka Yuri, Kosako Hidetaka, Butlertanaka Erika, Sengupta Prabuddha, Lippincott-Schwartz Jennifer, Saito Akatsuki, Yoshimura Shige
janelia7_blocks-janelia7_biblio_abstract | block

Abstract

Most mammalian cells prevent viral infection and proliferation by expressing various restriction factors and sensors that activate the immune system. While anti-human immunodeficiency virus type 1 (HIV-1) host restriction factors have been identified, most of them are antagonized by viral proteins. This has severely hindered their development in anti-HIV-1 therapy. Here, we describe CCHC-type zinc-finger-containing protein 3 (ZCCHC3) as a novel anti-HIV-1 factor that is not antagonized by viral proteins. ZCCHC3 suppresses production of HIV-1 and other retroviruses. We show that ZCCHC3 acts by binding to Gag nucleocapsid protein via zinc-finger motifs. This prevents interaction between the Gag nucleocapsid protein and viral genome and results in production of genome-deficient virions. ZCCHC3 also binds to the long terminal repeat on the viral genome via the middle-folded domain, sequestering the viral genome to P-bodies, which leads to decreased viral replication and production. Such a dual antiviral mechanism is distinct from that of any other known host restriction factors. Therefore, ZCCHC3 is a novel potential target in anti-HIV-1 therapy.

PMID: 38384847 [PubMed - indexed for MEDLINE]

node:body | entity_field

bioRxiv PrePrint https://doi.org/10.1101/2023.06.14.544911

janelia7_blocks-janelia7_biblio_authors | block

Janelia Authors

Prabuddha Sengupta
Jennifer Lippincott-Schwartz
janelia7_blocks-janelia7_biblio_tools | block